Answers are grounded in this paper and cite their sources.
Cross sectional case-control study shows serum Clara cell protein reliably predicts allergic rhinitis in children, indicating its potential as a non-invasive biomarker.
Background: Allergic rhinitis is among the most common chronic disorders of childhood with prevalence of up to 40% in children. Clara cell secretory protein (CCSP) is secreted by Clara cells in the lining fluid of airways. It has an immune-modulatory and anti-inflammatory activity. Aim of work: Study aimed at evaluating Clara cell secretory protein as a pneumoprotein biomarker in serum and nasal lavage fluid of children with allergic rhinitis. Methods: A cross sectional case-control study was conducted on sera and nasal lavage fluid samples from 15 children with allergic rhinitis, recruited from Children's hospital, Ain Shams University, and 15 healthy children as a control group. Results: Children with allergic rhinitis had a male to female ratio 2 to 1, with a mean age of 9.47±2.75 years, while among the healthy group, six were males and nine were females, with a mean age of 8.63±2.28 years. Rhinorrhea and nasal obstruction were the most frequent symptoms (100%) followed by itching (93.3%) then sneezing (73.3%). Serum CCSP mean±SD was 2.03±0.59μg/l; it was reliable to predict allergic rhinitis (P<0.0001); while nasal lavage CCSP mean±SD was 12.73±8.25μg/l and it was not reliable to predict allergic rhinitis. The best cut-off value was 3.75 μg/l with a sensitivity of 100%, specificity 80%, with a diagnostic accuracy of 90%. Conclusion: In conclusion, Clara cell secretory protein is a new peripheral sensitive marker of airway injury allowing researchers to evaluate the integrity of the air blood barrier. Furthermore, serum CCSP level is a non-invasive predictor of allergic rhinitis but not nasal lavage fluid CCSP.
No takes yet. Share an insight, caveat, or question.
Draz et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: